These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34187889)

  • 1. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading.
    Xu Y; Propson NE; Du S; Xiong W; Zheng H
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34187889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
    Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
    Olešová D; Dobešová D; Majerová P; Brumarová R; Kvasnička A; Kouřil Š; Stevens E; Hanes J; Fialová Ľ; Michalicová A; Piešťanský J; Šinský J; Kaňovský P; Friedecký D; Kováč A
    J Neuroinflammation; 2024 Mar; 21(1):78. PubMed ID: 38539208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.
    Weston LL; Jiang S; Chisholm D; Jantzie LL; Bhaskar K
    J Neuroinflammation; 2021 Jul; 18(1):161. PubMed ID: 34275478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atg7 deficiency in microglia drives an altered transcriptomic profile associated with an impaired neuroinflammatory response.
    Friess L; Cheray M; Keane L; Grabert K; Joseph B
    Mol Brain; 2021 Jun; 14(1):87. PubMed ID: 34082793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage.
    Shi H; Wang J; Wang J; Huang Z; Yang Z
    J Neuroimmunol; 2018 Oct; 323():143-151. PubMed ID: 28778418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically enhancing the expression of chemokine domain of CX
    Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K
    J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
    Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
    Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles.
    Glat M; Skaat H; Menkes-Caspi N; Margel S; Stern EA
    J Nanobiotechnology; 2013 Sep; 11():32. PubMed ID: 24059692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial reduction of microglia does not affect tau pathology in aged mice.
    Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
    J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model.
    Stancu IC; Lodder C; Botella Lucena P; Vanherle S; Gutiérrez de Ravé M; Terwel D; Bottelbergs A; Dewachter I
    Glia; 2022 Jun; 70(6):1117-1132. PubMed ID: 35174546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome activation drives tau pathology.
    Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
    Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy.
    Wang C; Fan L; Khawaja RR; Liu B; Zhan L; Kodama L; Chin M; Li Y; Le D; Zhou Y; Condello C; Grinberg LT; Seeley WW; Miller BL; Mok SA; Gestwicki JE; Cuervo AM; Luo W; Gan L
    Nat Commun; 2022 Apr; 13(1):1969. PubMed ID: 35413950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer's disease.
    Comerota MM; Gedam M; Xiong W; Jin F; Deng L; Wang MC; Wang J; Zheng H
    Mol Neurodegener; 2023 Aug; 18(1):56. PubMed ID: 37580742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional microglia and tau pathology in Alzheimer's disease.
    Ayyubova G
    Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
    Sasaki A; Kawarabayashi T; Murakami T; Matsubara E; Ikeda M; Hagiwara H; Westaway D; George-Hyslop PS; Shoji M; Nakazato Y
    Brain Res; 2008 Jun; 1214():159-68. PubMed ID: 18457819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.